Receive our newsletter – data, insights and analysis delivered to you
  1. Comment
August 23, 2018updated 15 Dec 2021 10:14am

US launches first vision and eye health surveillance system

The nation’s first Vision and Eye Health Surveillance System (VEHSS) was recently launched by the Centers for Disease Control and Prevention (CDC) in collaboration with the National Opinion Research Center (NORC). This surveillance initiative aims to help health care professionals and researchers gain a better understanding of the extent of vision loss, eye disorders, and eye care services in the US.

By GlobalData Healthcare

The nation’s first Vision and Eye Health Surveillance System (VEHSS) was recently launched by the Centers for Disease Control and Prevention (CDC) in collaboration with the National Opinion Research Center (NORC). This surveillance initiative aims to help health care professionals and researchers gain a better understanding of the extent of vision loss, eye disorders, and eye care services in the US.

VEHSS integrates recent and historical data obtained from national surveys, population-based studies, registries, electronic health records, and administrative claims. System users can leverage both state and national-level data to compile information on residents’ vision and eye health; analyse data across multiple sources using consistent case definitions; and analyse data to understand the prevalence, diagnosis, and treatment of eye disorders.

In the US, common eye disorders include age-related macular degeneration (AMD), glaucoma, and diabetic retinopathy. GlobalData estimates that three to eight million Americans were affected by these disorders in 2017 (as shown in Figure 1).

GlobalData epidemiologists believe that the implementation of the VEHSS may result in a change in the understanding of the epidemiology of both common and rare eye disorders, since the VEHSS dataset will allow for uniform case definitions, accurate case identification, trend analyses, and nationally representative studies of disease prevalence.

Content from our partners
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
The powerful networks advancing life sciences in Charleston | USA
The power of infrastructure: How Charleston | SC | USA is expanding horizons for life science companies
Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU